相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Advances in the clinical management of uveal melanoma
Richard D. Carvajal et al.
NATURE REVIEWS CLINICAL ONCOLOGY (2023)
A phase I trial of LXS196, a protein kinase C (PKC) inhibitor, for metastatic uveal melanoma
S. Piperno-Neumann et al.
BRITISH JOURNAL OF CANCER (2023)
Functional characterization of uveal melanoma oncogenes
Jiafang Ma et al.
ONCOGENE (2021)
Synthetic Lethal Screens Reveal Cotargeting FAK and MEK as a Multimodal Precision Therapy for GNAQ-Driven Uveal Melanoma
Justine S. Paradis et al.
CLINICAL CANCER RESEARCH (2021)
Clinical trial in progress: Phase II trial of defactinib (VS-6063) combined with VS-6766 (CH5126766) in patients with metastatic uveal melanoma.
Rino S. Seedor et al.
JOURNAL OF CLINICAL ONCOLOGY (2021)
Overall Survival Benefit with Tebentafusp in Metastatic Uveal Melanoma
Paul Nathan et al.
NEW ENGLAND JOURNAL OF MEDICINE (2021)
Preclinical evaluation of drug combinations identifies co-inhibition of Bcl-2/XL/W and MDM2 as a potential therapy in uveal melanoma
Didier Decaudin et al.
EUROPEAN JOURNAL OF CANCER (2020)
Genomic Profiling of Metastatic Uveal Melanoma and Clinical Results of a Phase I Study of the Protein Kinase C Inhibitor AEB071
Sophie Piperno-Neumann et al.
MOLECULAR CANCER THERAPEUTICS (2020)
A Platform of Synthetic Lethal Gene Interaction Networks Reveals that the GNAQ Uveal Melanoma Oncogene Controls the Hippo Pathway through FAK
Xiaodong Feng et al.
CANCER CELL (2019)
PARP Inhibition Increases the Response to Chemotherapy in Uveal Melanoma
Leanne De Koning et al.
CANCERS (2019)
The genetic evolution of metastatic uveal melanoma
A. Hunter Shain et al.
NATURE GENETICS (2019)
Emerging Therapeutic Opportunities Based on Current Knowledge of Uveal Melanoma Biology
Raquel Vivet-Noguer et al.
CANCERS (2019)
Selumetinib in Combination With Dacarbazine in Patients With Metastatic Uveal Melanoma: A Phase III, Multicenter, Randomized Trial (SUMIT)
Richard D. Carvajal et al.
JOURNAL OF CLINICAL ONCOLOGY (2018)
Selumetinib-based therapy in uveal melanoma patient-derived xenografts
Didier Decaudin et al.
Oncotarget (2018)
Uveal Melanoma: A Review of the Literature
Manni Singh et al.
ONCOLOGY AND THERAPY (2018)
Integrative Analysis Identifies Four Molecular and Clinical Subsets in Uveal Melanoma
A. Gordon Robertson et al.
CANCER CELL (2017)
Deep sequencing of uveal melanoma identifies a recurrent mutation in PLCB4
Peter Johansson et al.
ONCOTARGET (2016)
Recurrent activating mutations of G-protein-coupled receptor CYSLTR2 in uveal melanoma
Amanda R. Moore et al.
NATURE GENETICS (2016)
The mTOR inhibitor Everolimus synergizes with the PI3K inhibitor GDC0941 to enhance anti-tumor efficacy in uveal melanoma
Nabil Amirouchene-Angelozzi et al.
ONCOTARGET (2016)
The genetics of uveal melanoma: current insights
Hildur Helgadottir et al.
APPLICATION OF CLINICAL GENETICS (2016)
High-throughput screening using patient-derived tumor xenografts to predict clinical trial drug response
Hui Gao et al.
NATURE MEDICINE (2015)
Hippo-Independent Activation of YAP by the GNAQ Uveal Melanoma Oncogene through a Trio-Regulated Rho GTPase Signaling Circuitry
Xiaodong Feng et al.
CANCER CELL (2014)
Effect of Selumetinib vs Chemotherapy on Progression-Free Survival in Uveal Melanoma A Randomized Clinical Trial
Richard D. Carvajal et al.
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION (2014)
Establishment of novel cell lines recapitulating the genetic landscape of uveal melanoma and preclinical validation of mTOR as a therapeutic target
Nabil Amirouchene-Angelozzi et al.
MOLECULAR ONCOLOGY (2014)
Exome sequencing identifies recurrent somatic mutations in EIF1AX and SF3B1 in uveal melanoma with disomy 3
Marcel Martin et al.
NATURE GENETICS (2013)
Recurrent mutations at codon 625 of the splicing factor SF3B1 in uveal melanoma
J. William Harbour et al.
NATURE GENETICS (2013)
SF3B1 Mutations Are Associated with Alternative Splicing in Uveal Melanoma
Simon J. Furney et al.
CANCER DISCOVERY (2013)
Establishment and Characterization of a Panel of Human Uveal Melanoma Xenografts Derived from Primary and/or Metastatic Tumors
Fariba Nemati et al.
CLINICAL CANCER RESEARCH (2010)
Mutations in GNA11 in Uveal Melanoma.
Catherine D. Van Raamsdonk et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Frequent Mutation of BAP1 in Metastasizing Uveal Melanomas
J. William Harbour et al.
SCIENCE (2010)
Frequent somatic mutations of GNAQ in uveal melanoma and blue naevi
Catherine D. Van Raamsdonk et al.
NATURE (2009)
Frequent PTEN genomic alterations and activated phosphatidylinositol 3-kinase pathway in basal-like breast cancer cells
Berengere Marty et al.
BREAST CANCER RESEARCH (2008)
分享论文
